About Crystal Biosciences
Crystal Biosciences is a company based in Emeryville (United States) founded in 2008 was acquired by Ligand Pharmaceuticals in October 2017. Crystal Biosciences operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Emeryville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$216.9 K (USD), Grant
Aug 22, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Ligand Pharmaceuticals
(Oct 04, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Crystal Biosciences
Investors in Crystal Biosciences
Crystal Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Ligand Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Pharmaceutical drugs are manufactured and developed in the United States.
|
Locked | Locked | Locked |
Investor details for Crystal Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Crystal Biosciences
Investment portfolio details for Crystal Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Crystal Biosciences
Detailed financials for Crystal Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crystal Biosciences Comparisons
Peer comparison for Crystal Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Crystal Biosciences
Crystal Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Technology for antibody-drug conjugation is provided by AbTis.
|
Detailed competitors of Crystal Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crystal Biosciences
Complete news archive for Crystal Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crystal Biosciences
Crystal Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Crystal Biosciences is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Crystal Bioscience is an antibody discovery company. It provides panels of antibodies that have cross-species reactivity, abolishing the need to develop surrogate antibodies for use in pre-clinical studies. Technologies include crystal antibody, single b-cell screening, hu-mAb chicken, and in vivo molecular evolution.
Crystal Biosciences's top competitors include Sino Biological, GenScript and Y-Biologics.
Crystal Biosciences has 2 investors. Key investors include HHS, and Ligand Pharmaceuticals.